Drug Database
Back to search

France· FR:68005178

SIBNAYAL 8 mEq, granulés à libération prolongée

A medicinal product containing citrate de potassium + bicarbonate de potassium, registered in France by ADVICENNE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSIBNAYAL 8 mEq, granulés à libération…ATC—REGISTER NO.FR:68005178PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about citrate de potassium + bicarbonate de potassiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CITRATE DE POTASSIUM + BICARBONATE DE POTASSIUM
Manufacturer
ADVICENNE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930223086
    60 sachet(s) polyéthylène téréphtalate polyester aluminium polyéthylène basse densité (PEBD)
    EUR 71.46

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Citrate de potassium + bicarbonate de potassium in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All citrate de potassium + bicarbonate de potassium products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Potassium Bpc 1968 Accord-Uk
  • Greece · Exeret
  • Iceland · Sibnayal
  • Liechtenstein · Sibnayal
  • Norway · Sibnayal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb7bf1b2-a537-4e6d-8f7f-d8e379f614b1
GET /v1/drugs/cb7bf1b2-a537-4e6d-8f7f-d8e379f614b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68005178",
  "date_amm": "2021-04-30",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/20/1517",
  "substance": "CITRATE DE POTASSIUM + BICARBONATE DE POTASSIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granules à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about citrate de potassium + bicarbonate de potassium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console